De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

BICO Group Beheer

Beheer criteriumcontroles 2/4

De CEO BICO Group's is Maria Forss, benoemd in Nov2023, heeft een ambtstermijn van minder dan een jaar. De totale jaarlijkse vergoeding van { bedraagt SEK 7.43M, bestaande uit 6.5% salaris en 93.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.057% van de aandelen van het bedrijf, ter waarde $ 175.32K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.7 jaar en 4 jaar.

Belangrijke informatie

Maria Forss

Algemeen directeur

SEK 7.4m

Totale compensatie

Percentage CEO-salaris	6.5%
Dienstverband CEO	less than a year
Eigendom CEO	0.06%
Management gemiddelde ambtstermijn	1.7yrs
Gemiddelde ambtstermijn bestuur	4yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Maria Forss's beloning veranderd ten opzichte van BICO Group's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-SEK 1b
Mar 31 2024	n/a	n/a	-SEK 2b
Dec 31 2023	SEK 7m	SEK 484k	-SEK 2b

Compensatie versus markt: De totale vergoeding ($USD 730.78K ) Maria } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 2.40M ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Maria te vergelijken met de prestaties van het bedrijf.

CEO

Maria Forss (52 yo)

less than a year

Tenure

SEK 7,425,520

Compensatie

Ms. Maria Forss serves as President & CEO of BICO Group AB (publ) since November 20, 2023. She served as Senior Vice President of Consumables at Vitrolife AB (publ) since January 01, 2022 until August 2023...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Maria Forss	President & CEO	less than a year	SEK 7.43m	0.057% $ 159.8k
Jacob Thordenberg	Group Chief Financial Officer	1.8yrs	geen gegevens	0.026% $ 73.4k
Marius Balger	Chief Operating Officer	1.6yrs	geen gegevens	geen gegevens
Asa Hillsten	Senior VP & Head of Investor Relations	no data	geen gegevens	geen gegevens
Lotta Bus	SVP, General Counsel	4.8yrs	geen gegevens	0.0099% $ 27.9k
Artur Aira	Head of Corporate Development and M&A	1.6yrs	SEK 150.00k	geen gegevens
Catharina Nordlund	Global Head of Human Resources	less than a year	geen gegevens	geen gegevens
Itedale Redwan	Chief Scientific Officer - Bioprinting	no data	geen gegevens	geen gegevens
Niclas Emanuelsson	Head of Global Operations	4.8yrs	geen gegevens	geen gegevens
Holger Eickhoff	Senior VP & Business Area Director - Bioautomation	2.8yrs	geen gegevens	geen gegevens
Erica Bell	Senior VP & Chief People Officer	no data	geen gegevens	geen gegevens
Nicolas Gabriel-Robez	Chief Security Officer	no data	geen gegevens	geen gegevens

1.7yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CLLK.F wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.7 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Rolf Classon	Independent Chairman of the Board	2.5yrs	SEK 650.00k	0.044% $ 123.6k
Christian Wildmoser	Independent Director	4.8yrs	SEK 285.00k	0.45% $ 1.3m
Robert Langer	Member of Scientific Advisory Board	3.9yrs	geen gegevens	geen gegevens
Helena Skantorp	Independent Director	4.8yrs	SEK 350.00k	0.0057% $ 16.0k
Ulrika Dellby	Independent Deputy Chairwoman	2.5yrs	SEK 510.00k	0.027% $ 75.8k
Bengt Sjoholm	Independent Director	8.8yrs	SEK 285.00k	0.49% $ 1.4m
Susan Tousi	Independent Director	2.9yrs	SEK 250.00k	geen gegevens
Ali Khademhosseini	Member of Scientific Advisory Board	7.6yrs	geen gegevens	geen gegevens
Ido Amit	Member of Scientific Advisory Board	4.2yrs	geen gegevens	geen gegevens
Alexandra Gatzemeyer	Director	less than a year	geen gegevens	geen gegevens

4.0yrs

Gemiddelde duur

66.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CLLK.F wordt beschouwd als ervaren (gemiddelde ambtstermijn 4 jaar).

BICO Group Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

BICO Group AB (publ), Annual General Meeting, May 08, 2025

BICO Group AB Announces Management Changes

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

Recent updates

BICO Group AB (publ) to Report Fiscal Year 2024 Final Results on Mar 20, 2025

BICO Group AB (publ), Annual General Meeting, May 08, 2025

BICO Group AB Announces Management Changes

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025

BICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024

BICO Group AB (publ) Announces Chief Executive Officer Changes

Beos Light Industrial Germany 1 Fund, a fund managed by BEOS AG agreed to acquire property on Wagner-Régeny-Straße 15 from BICO Group AB (publ) (OM:BICO) for €21 million.

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024

BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023

BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFO

BICO Group AB (publ) to Report Q1, 2023 Results on May 04, 2023

BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

BICO Group Announces Appointment of Nomination Committee 2023

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023

BICO Group Adds Åsa Hillsten as SVP and Head of IR

BICO Group AB (publ) (OM : BICO) acquired Allegro 3D for $11 million.

BICO (publ) Appoints Mikael Engblom as Interim CFO

BICO Group AB (Publ) Announces Board Appointments

BICO Reaches Beneficial and Sustainable Solution with Organovo

DISPENDIX, A BICO Company, Announces That the I.DOT HT Non-contact Dispenser and the L.DROP Liquid Handler will be introduced at SLAS 2022

BICO Group AB Announces Statement Regarding Counterclaims in Patent Lawsuit by Organovo Against Cellink

BICO Group AB (publ) (OM:BICO) agreed to acquire Biosero Llc.

BICO Group AB (publ) (OM:BICO) acquired all outstanding shares in Advanced BioMatrix, Inc. for $18 million.

CELLINK Receives Patent for Robotic Systems for Personalized and Automated Aesthetic Medical Procedures

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Discover Echo Inc.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Nanoscribe GmbH for approximately €37 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Nanoscribe GmbH for €34 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire MatTek Corporation for $68 million.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Ginolis Ltd from Verso Fund II of Verso Capital Oy, Finnvera plc and Innovestor Ventures for €65.7 million.

Cellink AB (publ) to Report Fiscal Year 2021 Results on Mar 16, 2022

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Ginolis Ltd for €70 million.

Cellink AB (publ) Announces Distribution Agreement Including New Products for Single-Cell RNA Sequencing and NGS Library Preparation

Cellink Announces Third Year Extension of Collaboration with A Global Biopharmaceutical Company for Drug Discovery

Cellink and Phasefocus Announces a Partnership to Bring Livecyte High Content Live Cell Imager to a Wider Audience

Cellink AB (publ) Elects Aristotelis Nastos as Member of the Board of Directors

CELLINK and Atelerix Team Up to Enable the Shipping At Room Temperature of Fragile 3D Bioprinted Constructs by the World's Bioprinting Community

CELLINK to Help Develop 3D Bioprinted Personalised Scaffolds for Tissue Regeneration of Ankle Joint S as Part of the Triankle Project

Cellink AB (publ) to Report Second Half, 2020 Results on Oct 22, 2020

Cellink AB (Publ) Announces Leaving Board of Directors for an Operational Role as Business Area Manager for the Bioprinting Business Unit

Cellink AB (publ) (OM:CLNK B) completed the acquisition of SCIENION AG from NRW.Bank Venture Fonds, L.P., managed by NRW.Bank, Investment Arm and other shareholders.

Cellink AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 945.99632 million.

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd